|
New York, NY, November 17, 2009-Ebitda News reports that negative EBITDA for Ariad Pharmaceuaticals, Inc. (NASDAQ:ARIA) for its quarter ended September 30, 2009 was $(14,573,000), a 24% improvement ov ... read full story |
|
| Website Address: |
www.ariad.com |
| Industry: |
Bio-Pharma & Therapeutics
|
|